Non-integrative lentivirus drives high-frequency cre-mediated cassette exchange in human cells

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Torres, Raul ^a   García, Aida ^a   Payá, Monica ^a,b   Ramirez, Juan C ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b Biology Section Apdo 863 E 41080   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LENTIVIRUS VECTOR; RECOMBINASE; CRE RECOMBINASE; INTEGRASE;

ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DNA SCREENING; FUNCTIONAL GENOMICS; GENE CASSETTE; GENETIC TRANSFECTION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; LENTIVIRINAE; PROTEIN EXPRESSION; RECOMBINASE MEDIATED CASSETTE EXCHANGE ASSAY; SIGNAL TRANSDUCTION; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; GENETIC RECOMBINATION; GENETICS; KIDNEY; METABOLISM; PHYSIOLOGY; PLASMID; PROMOTER REGION; TRANSGENE; WESTERN BLOTTING;

LENTIVIRUS;

BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; INTEGRASES; KIDNEY; LENTIVIRUS; PLASMIDS; PROMOTER REGIONS, GENETIC; RECOMBINATION, GENETIC; TRANSGENES;

EID: 79956355672     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019794     Document Type: Article

References (39)

1. Branda CS, Dymecki SM, (2004) Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6: 7-28.
2. Wirth D, Gama-Norton L, Riemer P, Sandhu U, Schucht R, et al. (2007) Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol 18: 411-419.
3. Grindley ND, Whiteson KL, Rice PA, (2006) Mechanisms of site-specific recombination. Annu Rev Biochem 75: 567-605.
4. Lewandoski M, (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755.
5. Song H, Chung SK, Xu Y, (2010) Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6: 80-89.
6. Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, et al. (2009) Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 27: 851-857.
7. Redondo P, Prieto J, Munoz IG, Alibes A, Stricher F, et al. (2008) Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. Nature 456: 107-111.
8. Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee YL, et al. (2007) Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25: 1298-1306.
9. Groth AC, Calos MP, (2004) Phage integrases: biology and applications. J Mol Biol 335: 667-678.
10. Birling MC, Gofflot F, Warot X, (2009) Site-specific recombinases for manipulation of the mouse genome. Methods Mol Biol 561: 245-263.
11. Irion S, Luche H, Gadue P, Fehling HJ, Kennedy M, et al. (2007) Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol 25: 1477-1482.
12. Zwaka TP, Thomson JA, (2003) Homologous recombination in human embryonic stem cells. Nat Biotechnol 21: 319-321.
13. Di Domenico AI, Christodoulou I, Pells SC, McWhir J, Thomson AJ, (2008) Sequential genetic modification of the hprt locus in human ESCs combining gene targeting and recombinase-mediated cassette exchange. Cloning Stem Cells 10: 217-230.
14. Braam SR, Denning C, van den Brink S, Kats P, Hochstenbach R, et al. (2008) Improved genetic manipulation of human embryonic stem cells. Nat Methods 5: 389-392.
15. Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, et al. (2001) Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11: 514-518.
16. Sorrell DA, Robinson CJ, Smith JA, Kolb AF, (2010) Recombinase mediated cassette exchange into genomic targets using an adenovirus vector. Nucleic Acids Res 38: e123.
17. Silver DP, Livingston DM, (2001) Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233-243.
18. Naldini L, Verma IM, (2000) Lentiviral vectors. Adv Virus Res 55: 599-609.
19. Cronin J, Zhang XY, Reiser J, (2005) Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5: 387-398.
20. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, et al. (2007) Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 25: 1457-1467.
21. Delenda C, (2004) Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 6 (Suppl 1): S125-138.
22. Banasik MB, McCray PB Jr, (2010) Integrase-defective lentiviral vectors: progress and applications. Gene Ther 17: 150-157.
23. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880.
24. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
25. Butler SL, Hansen MS, Bushman FD, (2001) A quantitative assay for HIV DNA integration in vivo. Nat Med 7: 631-634.
26. Paya M, Segovia JC, Santiago B, Galindo M, del Rio P, et al. (2006) Optimising stable retroviral transduction of primary human synovial fibroblasts. J Virol Methods 137: 95-102.
27. Araki K, Araki M, Yamamura K, (1997) Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res 25: 868-872.
28. Lee G, Saito I, (1998) Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene 216: 55-65.
29. Kolb AF, (2001) Selection-marker-free modification of the murine beta-casein gene using a lox2272 [correction of lox2722] site. Anal Biochem 290: 260-271.
30. Ramezani A, Hawley TS, Hawley RG, (2000) Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2: 458-469.
31. de Felipe P, (2004) Skipping the co-expression problem: the new 2A "CHYSEL" technology. Genet Vaccines Ther 2: 13.
32. Rodolosse A, Barbat A, Chantret I, Lacasa M, Brot-Laroche E, et al. (1998) Selecting agent hygromycin B alters expression of glucose-regulated genes in transfected Caco-2 cells. Am J Physiol 274: G931-938.
33. Siegel RW, Jain R, Bradbury A, (2001) Using an in vivo phagemid system to identify non-compatible loxP sequences. FEBS Lett 505: 467-473.
34. Zaiss AK, Son S, Chang LJ, (2002) RNA 3′ readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy. J Virol 76: 7209-7219.
35. Qiao J, Oumard A, Wegloehner W, Bode J, (2009) Novel tag-and-exchange (RMCE) strategies generate master cell clones with predictable and stable transgene expression properties. J Mol Biol 390: 579-594.
36. Qasim W, Vink CA, Thrasher AJ, (2010) Hybrid lentiviral vectors. Mol Ther 18: 1263-1267.
37. Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, et al. (2006) Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12: 348-353.
38. Sakurai K, Shimoji M, Tahimic CG, Aiba K, Kawase E, et al. (2010) Efficient integration of transgenes into a defined locus in human embryonic stem cells. Nucleic Acids Res 38: e96.
39. Nolden L, Edenhofer F, Haupt S, Koch P, Wunderlich FT, et al. (2006) Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods 3: 461-467.